Abstract | BACKGROUND: Inflammatory damage aggravates the cerebral ischemic pathological process and may pave a new way for treatment. Bicyclol has been proved to elicit a series of biologic effects through its anti-inflammatory property in treating hepatitis and hepatic ischemic/ reperfusion injury. Whether this protective effect applies to cerebral ischemic injury, we therefore investigated the potential neuroprotective role of bicyclol and the underlying mechanisms. METHODS: Male Sprague-Dawley rats were randomly assigned to five groups: permanent middle cerebral artery occlusion (pMCAO), Vehicle (pMCAO+0.5% sodium carboxymethylcellulose), By-L (Vehicle+bicyclol 50 mg/kg), By-H (Vehicle+bicyclol 100 mg/kg) and Sham operated group. Bicyclol was administered intragastrically once a day for 3 days, after 1h of bicyclol pretreatment on the third day; rat brain ischemia was induced by pMCAO. Neurological deficit, infarct volume, and brain edema were measured at 24 h after stroke. Immunohistochemistry, Western blot and real-time quantitative PCR were used to detect the expression of TLR4, TLR9, TRAF6, NF-κB and MMP-9, claudin-5. RESULTS: Compared with pMCAO group, bicyclol significantly ameliorated neurological deficit, decreased infarct volume and edema, and down-regulated the expression of TLR4, TLR9, TRAF6, NF-κB and MMP-9 (P<0.05). Meanwhile, the expression of claudin-5 was increased (P<0.05). CONCLUSIONS:
|
Authors | Jian Zhang, Baosheng Fu, Xiangjian Zhang, Linyu Chen, Lan Zhang, Xumeng Zhao, Xue Bai, Chunhua Zhu, Lili Cui, Lina Wang |
Journal | Brain research
(Brain Res)
Vol. 1528
Pg. 80-8
(Aug 28 2013)
ISSN: 1872-6240 [Electronic] Netherlands |
PMID | 23850770
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Biphenyl Compounds
- Claudin-5
- Cldn5 protein, rat
- NF-kappa B
- Neuroprotective Agents
- TNF Receptor-Associated Factor 6
- Tlr4 protein, rat
- Tlr9 protein, rat
- Toll-Like Receptor 4
- Toll-Like Receptor 9
- bicyclol
- Matrix Metalloproteinase 9
|
Topics |
- Animals
- Biphenyl Compounds
(pharmacology)
- Brain
(drug effects, pathology)
- Claudin-5
(metabolism)
- Down-Regulation
- Infarction, Middle Cerebral Artery
(metabolism, pathology)
- Male
- Matrix Metalloproteinase 9
(metabolism)
- NF-kappa B
(metabolism)
- Neuroprotective Agents
(pharmacology)
- Rats
- Rats, Sprague-Dawley
- TNF Receptor-Associated Factor 6
(metabolism)
- Toll-Like Receptor 4
(metabolism)
- Toll-Like Receptor 9
(metabolism)
- Up-Regulation
|